Perspectives in Vascular Surgery and Endovascular Therapy

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to browse AJSM online!

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vijungco, J.
Right arrow Articles by Eskandari, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vijungco, J.
Right arrow Articles by Eskandari, M. K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Perspectives in Vascular Surgery and Endovascular Therapy, Vol. 17, No. 4, 279-287 (2005)
DOI: 10.1177/153100350501700402
© 2005 SAGE Publications

New Treatments for Cerebrovascular Disease

Joseph Vijungco, MD

Mark K. Eskandari, MD

Chicago, IL

Management of cerebrovascular disease involves medical and surgical therapies. Medical management, including antiplatelet therapy and statin therapy, has been mainstay treatment for the prevention of this disabling problem. Several studies have shown improved outcome in the prevention of stroke in patients who are taking these medications. Surgical management has also firmly established itself as an important modality in treating this disease. Several prospective, randomized trials have defined the patients that would have the most benefit from carotid endarterectomy. These include asymptomatic patients with a stenosis of 60% stenosis or more and symptomatic patients with a stenosis of 50% or more. The timing of carotid endarterectomy after stroke remains controversial, but recent studies advocate early carotid endarterectomy in a select group of patients. During the carotid endarterectomy, the method of closing of the arteriotomy has an overall effect on the safety of the procedure and on long-term outcome. Compared with primary repair of the arteriotomy, patch closure has been shown to decrease the frequency of restenosis. In addition, carotid eversion endarterectomy is an alternative method to remove the plaque and has an efficacy similar to standard carotid endarterectomy. The role of carotid angioplasty and stenting, which offers the patient a less invasive method of treating the carotid plaque, continues to evolve.

Key Words: cerebrovascular disease • carotid angioplasty • stenting • carotid endarterectomy • antiplatelet therapy


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?